These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3062384)

  • 1. p21-ras effector domain mutants constructed by "cassette" mutagenesis.
    Stone JC; Vass WC; Willumsen BM; Lowy DR
    Mol Cell Biol; 1988 Aug; 8(8):3565-9. PubMed ID: 3062384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural significance of the GTP-binding domain of ras p21 studied by site-directed mutagenesis.
    Clanton DJ; Lu YY; Blair DG; Shih TY
    Mol Cell Biol; 1987 Sep; 7(9):3092-7. PubMed ID: 3118192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasH.
    Willumsen BM; Vass WC; Velu TJ; Papageorge AG; Schiller JT; Lowy DR
    Mol Cell Biol; 1991 Dec; 11(12):6026-33. PubMed ID: 1658623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.
    Feig LA; Cooper GM
    Mol Cell Biol; 1988 Aug; 8(8):3235-43. PubMed ID: 3145408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ras effector domain mutant which is temperature sensitive for cellular transformation: interactions with GTPase-activating protein and NF-1.
    DeClue JE; Stone JC; Blanchard RA; Papageorge AG; Martin P; Zhang K; Lowy DR
    Mol Cell Biol; 1991 Jun; 11(6):3132-8. PubMed ID: 2038322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene.
    Pillaire MJ; Margot A; Villani G; Sarasin A; Defais M; Gentil A
    Nucleic Acids Res; 1994 Jul; 22(13):2519-24. PubMed ID: 8041613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of NIH3T3 cells with synthetic c-Ha-ras genes.
    Kamiya H; Miura K; Ohtomo N; Koda T; Kakinuma M; Nishimura S; Ohtsuka E
    Jpn J Cancer Res; 1989 Mar; 80(3):200-3. PubMed ID: 2542206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mammalian ras effector function.
    Hall A; Calés C; Hancock JF; Lloyd A; Self A; Gardener S; Houslay MD; Wakelam MJ; Marshall CJ
    Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 2():855-62. PubMed ID: 3076100
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of active ras oncogenes in human bladder cancers associated with schistosomiasis.
    Fujita J; Nakayama H; Onoue H; Rhim JS; el-Bolkainy MN; el-Aaser AA; Kitamura Y
    Jpn J Cancer Res; 1987 Sep; 78(9):915-20. PubMed ID: 3117747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
    Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
    Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of human N-ras and K-ras genes containing the Asn17 dominant negative mutation.
    Kaplan JB
    Oncol Res; 1994; 6(12):611-5. PubMed ID: 7787254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of amino acid residues required for Ras p21 target activation.
    Marshall MS; Davis LJ; Keys RD; Mosser SD; Hill WS; Scolnick EM; Gibbs JB
    Mol Cell Biol; 1991 Aug; 11(8):3997-4004. PubMed ID: 1906576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
    Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
    J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras gene mutation and amplification in human nonmelanoma skin cancers.
    Pierceall WE; Goldberg LH; Tainsky MA; Mukhopadhyay T; Ananthaswamy HN
    Mol Carcinog; 1991; 4(3):196-202. PubMed ID: 2064725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.
    Stone JC; Colleton M; Bottorff D
    Mol Cell Biol; 1993 Dec; 13(12):7311-20. PubMed ID: 8246952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma membrane-targeted ras GTPase-activating protein is a potent suppressor of p21ras function.
    Huang DC; Marshall CJ; Hancock JF
    Mol Cell Biol; 1993 Apr; 13(4):2420-31. PubMed ID: 8455619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.
    Nur-E-Kamal MS; Varga M; Maruta H
    J Biol Chem; 1993 Oct; 268(30):22331-7. PubMed ID: 8226742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harvey ras genes transform without mutant codons, apparently activated by truncation of a 5' exon (exon -1).
    Cichutek K; Duesberg PH
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2340-4. PubMed ID: 3517865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.